Fundraising Fox
Sense Neuro Diagnostics
Founded 2017 · 13 employees on LinkedIn · 1 known investors
Find your way into Sense Neuro Diagnostics
Sign up to find every way you can get introduced to Sense Neuro Diagnostics
- Your email: who you already know at Sense Neuro Diagnostics, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Sense Neuro Diagnostics team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Sense Neuro Diagnostics is developing non-invasive technology to rapidly detect stroke subtype and traumatic brain injury and to continuously monitor brain injury, producing a scan in 2.5 seconds that analyzes the entire cranial vault. Its investigational device, NeuroHawk, is intended for medical personnel and is pending FDA De Novo review.
Founders & leadership
Sense Neuro Diagnostics was founded in 2017 by George "Chip" Shaw.
Investors · 1
Non-dilutive funding · 2 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Science Foundation | Phase II | 2016 | $750K |
| National Science Foundation | Phase I | 2015 | $149.4K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Sense Neuro Diagnostics do?
- Sense Neuro Diagnostics is developing non-invasive technology to rapidly detect stroke subtype and traumatic brain injury and to continuously monitor brain injury, producing a scan in 2.5 seconds that analyzes the entire cranial vault. Its investigational device, NeuroHawk, is intended for medical personnel and is pending FDA De Novo review.
- Who founded Sense Neuro Diagnostics?
- Sense Neuro Diagnostics was founded by George "Chip" Shaw in 2017.
- Who are Sense Neuro Diagnostics's investors?
- Sense Neuro Diagnostics's investors include Angel Physicians Fund.